get a key
steadybase-$ company DYN
account_id none on file
legal_name Dyne Therapeutics, Inc.
ticker DYN
cik 1818794
domain dyne-tx.com
entry_point_account_id none on file
name Dyne Therapeutics Inc.
exchange Nasdaq
sector Health Care
calls 0 filings 50 executives 2 family 0
why_nownone on file
callsnone on file
filings
General and administrative expenses also include legal fees relating to patent and corporate matters; professional fees for accounting, auditing, tax and administrative consulting services; insurance costs; administrative travel expenses; commercial readiness activities; and facility-related expenses, which include allocated expenses for rent, depreciation and maintenance of facilities and other operating costs.

filing / Jul 29, 2026 / receipt

Cost reduction initiatives and other provisions of this legislation could decrease the coverage and price that we receive for any approved products.

filing / Jul 29, 2026 / receipt

In addition, there can be considerable pressure by governments and other stakeholders on prices and reimbursement levels, including as part of cost containment measures.

filing / Jul 29, 2026 / receipt

Pursuant to President Trump's executive order 14210, “Implementing the President’s ‘Department of Government Efficiency’ Workforce Optimization Initiative,” the Secretary of HHS announced on March 27, 2025, a reorganization and Reduction in Force, or RIF, across HHS of approximately 20,000 employees (82,000 to 62,000), with the FDA’s workforce of approximately 20,000 to decrease by 3,500 full-time employees.

filing / Jul 29, 2026 / receipt

General and administrative expenses also include legal fees relating to patent and corporate matters; professional fees for accounting, auditing, tax and administrative consulting services; insurance costs; administrative travel expenses; commercial readiness activities; and facility-related expenses, which include allocated expenses for rent, depreciation and maintenance of facilities and other operating costs.

filing / May 11, 2026 / receipt

The increase in personnel-related expenses was primarily due to increased headcount in our research and development function of 37 employees and higher stock-based compensation expense for awards granted to new hires and existing employees.

filing / May 11, 2026 / receipt

The increase in personnel-related and stock-based compensation expenses in the three months ended March 31, 2026 compared to the three months ended March 31, 2025 was due to increased headcount in our general and administrative function of 34 employees.

filing / May 11, 2026 / receipt

Cost reduction initiatives and other provisions of this legislation could decrease the coverage and price that we receive for any approved products.

filing / May 11, 2026 / receipt

In addition, there can be considerable pressure by governments and other stakeholders on prices and reimbursement levels, including as part of cost containment measures.

filing / May 11, 2026 / receipt

Pursuant to President Trump's executive order 14210, “Implementing the President’s ‘Department of Government Efficiency’ Workforce Optimization Initiative,” the Secretary of HHS announced on March 27, 2025, a reorganization and Reduction in Force, or RIF, across HHS of approximately 20,000 employees (82,000 to 62,000), with the FDA’s workforce of approximately 20,000 to decrease by 3,500 full-time employees.

filing / May 11, 2026 / receipt

Associate Director, Clinical Operations Study Lead | {"ats": "greenhouse", "city": "Waltham", "state": "MA", "job_id": "6188445004", "remote": false, "category": "other", "function": "operations", "lo

company_statement / Sep 11, 2026 / receipt

Associate Director, HCP Marketing - DMD | {"ats": "greenhouse", "city": null, "state": null, "job_id": "6190471004", "remote": true, "category": "other", "function": "marketing", "location": "Remote",

company_statement / Sep 11, 2026 / receipt

executives
Erick Lucera Chief Financial Officer linkedin receipt
John Cox President and Chief Executive Officer - receipt
familynone on file
upcoming
2026-11-04 earnings call scheduled ir
changes
2025-03-20 Chief Financial Officer, appointed sec_8k
2024-03-25 President and Chief Executive Officer, appointed sec_8k
mcp_package_hint
steadybase-$